Bank Of America Corp Pharvaris N.V. Transaction History
Bank Of America Corp
- $1.19 Trillion
- Q3 2024
A detailed history of Bank Of America Corp transactions in Pharvaris N.V. stock. As of the latest transaction made, Bank Of America Corp holds 15 shares of PHVS stock, worth $267. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 6,121
99.75%
Holding current value
$267
Previous $115,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PHVS
# of Institutions
53Shares Held
39.7MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$135 Million5.17% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$78.5 Million53.23% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$76.6 Million65.3% of portfolio
-
Viking Global Investors LP3.65MShares$65.2 Million0.26% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$60.6 Million6.51% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $603M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...